Chetan Joshi

Managed client-facing technical discussions and led development and scale-up of cost-effective, non-infringing processes for drug intermediates and APIs, enabling successful bench-to-kilo lab tech transfers and improved synthetic robustness.

Developed palladium-catalyzed asymmetric Aza-Heck methods and used DFT to elucidate reaction mechanisms, strengthening novelty claims and scope for pseudoindoxyl synthesis.

Led mechanistic and method-development projects in transition-metal, organocatalytic, and photoredox systems using kinetic isotope effects and DFT, contributing to multiple publications and collaborative NIH-funded programs.

Developed a de novo, efficient route to multi-substituted piperidines with strong diastereoselectivity and evaluated routes against literature standards for pharmaceutical relevance.

Designed and optimized synthetic routes for spatially directional resorcin[4]arene cavitands to enable targeted organic transformations and catalysis studies.

Designed and optimized synthetic routes for novel metal complexes and hybrid nanomaterials for photocatalytic organic transformations and coordinated collaborations with external partners.

Postdoctoral Associate conducting method development and mechanistic studies of palladium-catalyzed asymmetric Aza-Heck reactions and DFT investigations.

Ph.D. in Organic Chemistry focused on mechanistic studies and method development of transition-metal catalyzed, organocatalytic, and photoredox systems using kinetic isotope effects and DFT.

Completed M.S. in Organic Chemistry with coursework and research in organic synthesis and catalysis.

Completed B.S. in Chemistry covering foundational topics in chemical sciences.